Biotech · Private company
Inmagene LLC
Track this companyFree. Adds Inmagene LLC to your Dealase workspace and tells you when its record changes.
Clinical trials62 recruiting or active
Pipeline programs8From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline8
- ABY-035Phase 2 · Ankylosing SpondylitisClinicalTrials.gov · fetched Nov 12, 2026
- IMG-007Phase 2 · Alopecia Areata (AA)ClinicalTrials.gov · fetched Nov 12, 2026
- IMG-007Phase 2 · Atopic DermatitisClinicalTrials.gov · fetched Nov 12, 2026
- SAD IMG-004 100mgPhase 1 · Healthy ParticipantsClinicalTrials.gov · fetched Nov 12, 2026
- SAD IMG-004 200mgPhase 1 · Healthy ParticipantsClinicalTrials.gov · fetched Nov 12, 2026
- SAD IMG-004 30mgPhase 1 · Healthy ParticipantsClinicalTrials.gov · fetched Nov 12, 2026
- SAD IMG-004 400mgPhase 1 · Healthy ParticipantsClinicalTrials.gov · fetched Nov 12, 2026
- SAD IMG-004 600mgPhase 1 · Healthy ParticipantsClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials6
- Long-term Safety and Efficacy Evaluation of IMG-007 in Participants With Moderate-to-Severe Atopic DermatitisPHASE2 · ENROLLING_BY_INVITATION · started Jun 5, 2026ClinicalTrials.gov NCT07734415 · fetched Nov 12, 2026
- A Study to Evaluate the Efficacy and Safety of IMG-007 in Adult Participants With Moderate-to-Severe Atopic DermatitisPHASE2 · RECRUITING · started Jun 17, 2025ClinicalTrials.gov NCT07037901 · fetched Nov 12, 2026
- A Study to Evaluate the Safety, Pharmacokinetics and Efficacy of IMG-007 in Adult Alopecia Areata ParticipantsPHASE1_PHASE2 · COMPLETED · started Sep 25, 2023ClinicalTrials.gov NCT06060977 · fetched Nov 12, 2026
- A Study to Evaluate the Safety, Pharmacokinetics, and Efficacy of IMG-007 in Adults With Atopic Dermatitis (AD)PHASE1_PHASE2 · TERMINATED · started Aug 9, 2023ClinicalTrials.gov NCT05984784 · fetched Nov 12, 2026
- Study to Evaluate IMG-004 in Healthy ParticipantsPHASE1 · COMPLETED · started Aug 8, 2022ClinicalTrials.gov NCT05349097 · fetched Nov 12, 2026
- ABY-035 in the Treatment of Subjects With Ankylosing SpondylitisPHASE2 · TERMINATED · started Aug 24, 2021ClinicalTrials.gov NCT04795141 · fetched Nov 12, 2026